Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Ulcerative colitis is a debilitating and incurable condition. But researchers have found fresh angles of attack, and a host of upcoming treatments raise the prospect of a durable victory against this common form of inflammatory bowel disease.
This Nature Outline is editorially independent. It is produced with third party financial support. About this content.
Existing treatments for debilitating gut inflammation can offer only temporary relief. An array of potential therapies look set to unlock lasting remission.
Existing treatments bring only temporary relief to people with ulcerative colitis, a common form of inflammatory bowel disease. Insights into the immunobiology of the condition are driving the development of therapies that could lead to prolonged periods of remission.